Diagnosis and treatment of pediatric brain tumors
Open Access
- 5 March 2025
- journal article
- Published by Publishing House ABV Press in MD-Onco
- Vol. 5 (1) , 47-58
Abstract
Brain tumors are the most common solid tumors in children and are associated with high mortality. The most common childhood brain tumors are grouped as lowgrade gliomas, high grade gliomas, ependymomas, and embryonal tumors, according to the World Health Organization (WHO). Advances in molecular genetics have led to a shift from pure histopathological diagnosis to integrated diagnosis. For the first time, these new criteria were included in the WHO classification published in 2016 and has been further updated in the 2021 edition. Integrated diagnosis is based on molecular genomic similarities of the tumor subclasses, and it can better explain the differences in clinical courses of previously histopathologically identical entities. Important advances have also been made in pediatric neurooncology. A growing understanding of the moleculargenetic background of tumorigenesis has improved the diagnostic accuracy. Restratification of treatment protocols and the development of targeted therapies will significantly affect overall survival and quality of life. For some pediatric tumors, these advances have significantly improved therapeutic management and prognosis in certain tumor subgroups. Some therapeutic approaches also have serious longterm consequences. Therefore, optimized treatments are greatly needed.Keywords
This publication has 67 references indexed in Scilit:
- Imaging of pediatric brain tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee/ASPNR White PaperPediatric Blood & Cancer, 2022
- Efficacy of Carboplatin and Isotretinoin in Children With High-risk MedulloblastomaJAMA Oncology, 2021
- Children with DIPG and high-grade glioma treated with temozolomide, irinotecan, and bevacizumab: the Seattle Children’s Hospital experienceJournal of Neuro-Oncology, 2020
- Surgical approaches in pediatric neuro-oncologyCancer and Metastasis Reviews, 2019
- MYCN amplification drives an aggressive form of spinal ependymomaActa Neuropathologica, 2019
- Switching from linear to macrocyclic gadolinium‐based contrast agents halts the relative T1‐Weighted signal increase in deep gray matter of children with brain tumors: A retrospective studyJournal of Magnetic Resonance Imaging, 2019
- Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcomeActa Neuropathologica, 2017
- The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsActa Neuropathologica, 2016
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summaryActa Neuropathologica, 2016
- Management of intracranial hypertensionIndian Journal of Pediatrics, 2009